“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart

Article: Evans blue as a diagnostic tool for non-muscle-invasive bladder cancer: a preclinical study

€3.03

SKU: product-article-11021 Category: General

Description
Reviews (0)

Description

Evans blue as a diagnostic tool for non-muscle-invasive bladder cancer: a preclinical study

Reviews

There are no reviews yet.

Be the first to review “Article: Evans blue as a diagnostic tool for non-muscle-invasive bladder cancer: a preclinical study”

You must be logged in to post a review.

Top

Article: Evans blue as a diagnostic tool for non-muscle-invasive bladder cancer: a preclinical study

Description

Reviews

Related products

1 year subscription print edition of the Belgian Journal of Hematology (BJH)

Article: Highlights in gynaecological cancers

Article: Highlights in melanoma

Article: INTRODUCTION